VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME

REVERSING AGING OF THE CENTRAL NERVOUS SYSTEM

PROGRAMMABLE RECRUITMENT OF TRANSCRIPTION FACTORS TO ENDOGENOUS GENES

HUMAN T CELL RECEPTOR PAIRS REACTIVE WITH HLA-A*02:01 RESTRICTED HUMAN PROSTATIC ACID PHOSPHATASE (PAP) EPITOPES

GRANULIN/EPITHELIN MODULES AND COMBINATIONS THEREOF TO TREAT NEURODEGENERATIVE DISEASE

ANTI-FIBROUS CELLS, MEDICAMENT COMPRISING THE CELLS, AND METHOD FOR OBTAINING THESE CELLS

COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES

COMPOSITIONS AND METHODS FOR IMPROVING VIRAL VECTOR EFFICIENCY

Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery

SCALABLE LENTIVIRAL VECTOR PRODUCTION SYSTEM COMPATIBLE WITH INDUSTRIAL PHARMACEUTICAL APPLICATIONS

Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery

Protein-based purification matrices and methods of using the same

Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells using microcarriers

Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery

Gene editing method using virus

Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validation

VCN enhancer compositions and methods of using the same

SCALABLE LENTIVIRAL VECTOR PRODUCTION SYSTEM COMPATIBLE WITH INDUSTRIAL PHARMACEUTICAL APPLICATIONS

Induced pluripotent stem cells produced from dendritic cells

Lentiviral vectors for expression of hepatitis B virus (HBV) antigens

Compositions and methods for self-adjuvanting vaccines against microbes and tumors

Compositions and methods for improving viral vector efficiency

Lentiviral protein delivery system for RNA-guided genome editing

Compositions and methods for self-adjuvanting vaccines against microbes and tumors

Immunogenic compositions comprising FIV and HIV gag antigens

Lentiviral vectors containing an MHC class I promoter

Compositions and methods for self-adjuvanting vaccines against microbes and tumors

MATERIALS AND METHODS FOR DETECTING, PREVENTING, AND TREATING RETROVIRAL INFECTION

HIV DNA vaccine methods of use

DNA vaccine compositions with HIV/SIV gene modifications

METHODS AND COMPOSITIONS TO ENHANCE VACCINE EFFICACY BY REPROGRAMMING REGULATORY T CELLS

Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases

Compounds for immunopotentiation

Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens

Method of inhibiting lentiviral infectivity utilizing zinc chelation to inhibit Vif activity

Vascular endothelial growth factor dimers